The filmmaker explains why no sequel is in his future, despite strong reviews and promising box office tracking.

“The best figures we can come up with for using these kinds of medications is between a third and 50 per cent of people ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...